Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Ruxolitinib treatment may cause eyelash growth.

The conclusion suggests a new acne treatment that controls bacteria by reducing water in the skin's pores using sugar-like substances.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.